The Management of Sarcoidosis by the Primary Care Physician

American Journal of Medicine

Volumn 120, Issue 5, 2007, Pages 403-407

  Judson, Marc A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Extrapulmonary; Pulmonary; Sarcoidosis; Treatment

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PENTOXIFYLLINE; PREDNISONE;

ARTICLE; BLADDER CANCER; BLOOD CELL; CLINICAL FEATURE; DISEASE COURSE; DRUG HYPERSENSITIVITY; GASTROINTESTINAL SYMPTOM; GRANULOMATOSIS; HEMORRHAGIC CYSTITIS; HUMAN; IDIOPATHIC DISEASE; LIVER TOXICITY; LUNG SARCOIDOSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETINA INJURY; SARCOIDOSIS; SIDE EFFECT; THRUSH; TREATMENT INDICATION; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 34247276578     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.07.047     Document Type: Note

References (17)

1. Rybicki B.A., Major M., Popovich Jr. Y., Maliarik M.J., and Iannuzzi M.C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145 (1997) 234-241
2. Hunninghake G.W., Costabel U., Ando M., et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoid Vasc Diff Lung Dis 16 (1999) 149-173
3. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164 (2001) 1885-1889
4. Lynch J.P., Kazerooni E.A., and Gay S.E. Pulmonary sarcoidosis. Clin Chest Med (1997) 755-785
5. Shorr A.F., Helman D.L., Davies D.B., and Nathan S.D. Sarcoidosis, race, and short-term outcomes following lung transplantation. Chest 125 (2004) 990-996
6. Winterbauer R.H., and Hutchinson J.F. Use of pulmonary function tests in the management of sarcoidosis. Chest (1980) 640-647
7. Judson M.A. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest 115 (1999) 1158-1165
8. Ohara K., Judson M.A., and Baughman R.P. Clinical aspects of ocular sarcoidosis. Eur Respir J Monogr. 10 (2005) 188-209
9. Sharma O.P. Renal sarcoidosis and hypercalcemia. Eur Respir J Monogr. 10 (2005) 220-232
10. Schulte W., Kirstien D., Drent M., and Costabel U. Cardiac involvement in sarcoidosis. Eur Respir J Monogr. 10 (2005) 130-149
11. Yazaki Y, Osobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 88:1006-1010.
12. Uemura A., Morimoto S., Hiramitsu S., et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138 (1999) 299-302
13. Chapelon-Abric C., de Zuttere D., DuHaut P., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine. 83 (2004) 315-334
14. Umetani K., Ishihara T., Sawanobori T., et al. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of Gallium-67 and thallium-201 scintigraphy. Intern Med 39 (2000) 245-248
15. Vignaux O., Dhote R., Duboe D., et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. Chest 122 (2002) 1895-1901
16. Okumura W., Iwasaki T., Toyama T., et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 45 (2004) 1989-1998
17. Mezaki T., Chinushi M., Washizuka T., et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis: requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 40 (2001) 731-735